Atlas Trials

A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)

Clinical trial NCT02893618 · UNKNOWN

Trial details

NCT number
NCT02893618
Sponsor
Essentialis, Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Prader-Willi Syndrome
Start date
2017-07-01
Primary completion
2017-10-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.